Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUMM: Pharmacokinetically-Driven Dosing of MMF in Pediatric Lupus Nephritis
NCT05538208Phase 2Recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jun 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil in lupus nephritis (LN), sponsored by Cincinnati Children's Hospital Medical Center. Started Jun 2024; status: recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT05538208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05538208.